FDAnews Drug Daily Bulletin

ACCESS PHARMACEUTICALS RECEIVES NOTICE FROM AMEX THAT ITS COMMON STOCK IS SUBJECT TO BEING DELISTED

Dec. 20, 2005
A A

ACCESS PHARMACEUTICALS, INC. (Amex: AKC) today announced that the Company received notice from the staff of the American Stock Exchange ("AMEX") indicating that the Company no longer complies with AMEX's continued listing standards due to losses from continuing operations and/or net losses in two of its most recent fiscal years with shareholders' equity of less than $2 million, as set forth in Section 1003(a) (i) of the AMEX "Company Guide"; due to losses from continuing operations and/or net losses in three of its most recent fiscal years with shareholders' equity of less than $4 million, as set forth in Section 1003(a) (ii) of the Company Guide; and due to losses from continuing operations and/or net losses in four of its most recent fiscal years with shareholders' equity of less than $6 million, as set forth in Section 1003(a) (iii) of the Company Guide.

Houston Chronicle (http://www.chron.com/disp/story.mpl/prn/texas/3530358.html)